Clinical Trial Update: Methylprednisolone With or Without Daclizumab in Treating Patients With Acute Graft-Versus-Host Disease [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing methylprednisolone with or without daclizumab for acute graft-versus-host disease has completed and reported results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Daclizumab (daclizumab)
• METHYLPREDNISOLONE (methylprednisolone)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Graft Versus Host Disease | Phase 3 | Status: COMPLETED